Background
Thyroid cancer is a relatively rare neoplasm worldwide [
1], but the most common malignant disease of the endocrine system [
2]. A rapid increase in the incidence rate of thyroid cancer has been reported in the past several decades in many countries including China [
3‐
6]. The global age-standardized thyroid cancer incidence rates had an average increase of 58.1% from 1970 to 2002 [
3], with geographical differences. Northern European countries, Australia and Japan experienced a relatively low incidence and a little increase [
7,
8] whereas steep upward trends of thyroid cancer were observed in southern European countries [
9,
10], the United States [
11‐
13] and most markedly in the Republic of Korea [
14]. In China, a clear increase in the incidence was also reported by previous studies [
15‐
17]. The histologic type of thyroid cancer which contributes to the highest increase in the incidence in the world is papillary thyroid cancer (PTC) [
10,
12,
18]. This rapid increase has caused widespread public concern about thyroid cancer.
The underlying causes of this increasing trend remain unknown. This change may be partly attributable to environmental risk factors, including a deficit or excess of iodine intake [
19], medical radiation [
20] and nutrition-related factors [
21]. The use of advanced diagnostic techniques, such as ultrasound examination, computed tomography and magnetic resonance imaging scanning, and much more sensitive biochemical markers, which are more prone to the discovery of the thyroid nodules, have been proposed as the main reasons for the increasing trend [
14,
22‐
24].
On the other hand, quite a few studies have reported that the mortality rates have not increased or have even declined in most countries in the world [
7,
25,
26]. Therefore, the following questions were raised: (1) What is the reason for different trends between incidence and mortality of thyroid cancer? (2) What is the changing trend in clinical-pathological parameters? To address these questions, we analyzed the temporal distributions of thyroid cancer incidence and mortality in the population-based cancer registries of Zhejiang Province from 2000 to 2012, and the trends in the clinical-pathological parameters of thyroid cancer patients in Zhejiang Cancer Hospital from 1972 to 2014.
Discussion
In our study, we found an ongoing epidemic of thyroid cancer in Zhejiang, China. The incidence of thyroid cancer increased remarkably from 2000 to 2012 with an APC of 22.86%. During the period 2000–2012, the incidence rates dramatically changed more than 7-fold, while the mortality rates remained stable. Furthermore, from 1972 to 2014, we observed an increase in the proportion of PTC occurring in Zhejiang Cancer Hospital, especially papillary thyroid microcarcinoma (PTMC) with MTD < 1 cm.
Thyroid cancer accounts for only 1–2% of all malignancies worldwide [
29], but despite this, it remains the most common endocrine malignancy [
30]. In 2012, the global age-standardized incidence rate by world population (ASIRW) of thyroid cancer was 4.0/10
5, while China had at a relatively low level of incidence (the ASIRW was 2.8/10
5) [
31]. Zhejiang is an eastern coastal province of China, which belongs to comparatively economically developed regions [
15]. In a previous report, we concluded that the ASIRW of thyroid cancer in Zhejiang was obviously much higher than the national level. For example, in the year of 2010, the ASIRW of thyroid cancer in Zhejiang was 10.74/10
5, and the ASIRW of thyroid cancer throughout China was only 3.23/10
5 by contrast [
31]. Thus, more attention should be focused on thyroid cancer prevention and control in Zhejiang. Compared with our previous study [
32] published in 2014, this current study with more information and larger sampling size places emphasis on the secular trends of incidence and mortality, while the previous study provided a more comprehensive description of the epidemiological characteristics of thyroid cancer in six cancer registries of Zhejiang during 2000–2009. By comparison, the APC of incidence from 2000 to 2009 was 16.32% [
32], while the APC in 2000–2012 was 22.86%; furthermore, this current study showed that the APC was 0.06% in 2000–2003, 14.02% in 2003–2006, and 29.59% in 2006–2012. The APC of mortality from 2000 to 2009 was 2.14% [
32], while the APC from 2000 to 2012 decreased to 2.05%. Thus, we concluded that the incidence of thyroid cancer in Zhejiang has increased rapidly in recent years, whereas the mortality has remained relatively stable or even decreased.
The variation in the incidences of thyroid cancer during recent decades is mainly attributable to PTC. PTC is the most common type of thyroid cancer, with a low degree of malignancy and a good prognosis [
1]. Moreover, our findings suggest that the diagnosis of PTMC has contributed to the dramatic increase in cases since 2008. And in Zhejiang Province, the B ultrasonography of thyroid was gradually included in the routine physical examination starting from the years of 2008–2010, and now has been spread to the whole province. Because of the use of B ultrasonography, abnormalities often present in people who hardly develop symptoms [
33,
34]. This argument is corroborated by other epidemiological studies showing an increase in PTC diagnosis at the expense of PTMC [
11,
35]. These tumors are known to have a lower risk and better surgical outcome. Davies and Welch [
11] found that the major increases in PTC were in tumors < 2 cm in USA from 1988 to 2002. Using a cohort of 13,793 thyroidectomies patients performed over 40 years, Grodski et al. concluded that there was no increase in cancer incidence when PTMC were excluded [
36].
There seems to be an over diagnosis epidemic instead of an epidemic disease. Researchers concluded in the past that the increase in the incidence rates reflects the increased detection of subclinical disease, not an increase in the true occurrence of thyroid cancer due to the increase in PTMC [
11]. Davies L et al. found that the incidence of thyroid cancer in the United States more than doubled over the past 30 years and that 87% of the increase was due to the diagnosis of small papillary cancers [
11]. Our study also showed that the incidence of non-PTMC (papillary thyroid carcinoma with MTD > 1 cm) increased during the last 42 years. However, the change in trend of PTMC was more obvious than that of non-PTMC. Most probably, the trends reflect an increase in the environmental risk, boosted by augmented diagnostic activity, following more careful pathological examination. The presumed explanation for the observed increasing trend of thyroid cancer is the advanced diagnostic technique or increased attention to small nodules.
Data from Zhejiang Cancer Hospital showed that the highest proportion of the thyroid cancer cases was in the 40–59 age group. A possible explanation is that the residents aged 40–59 years might pay more attention to the physical examinations as they enter early old age. Moreover, compared to rural areas, papillary thyroid cancer incidence rates started higher in urban areas and increased faster. The detection level in urban areas is greater than that in rural areas because the urban residents seem to take the physical examination far more seriously. A Chinese study has demonstrated that more than 80% of the thyroid cancer cases in Hangzhou, the capital city in Zhejiang Province, were detected due to routine physical examinations [
32].
It is currently unclear whether the observed increase in thyroid cancer is real or due to increased diagnosis. However, it has been shown that the increase of comprehensive medical tests in the general population has led to an increased diagnosis of thyroid cancer; the impacts of changes in medical practices and the refined diagnostic techniques have been reported by many authors [
3,
37,
38]. Diagnostic sensitivity and opportunities for detection have improved over the past decades with the introduction of thyroid ultrasound in the early 1980s and final-needle aspiration technology in the late 1980s [
2]. These technologies could have potentially impacted the secular trends in one gender more than the other. We found statistically significant temporal and age-related differences for females and males. The incidence of thyroid cancer is 2.26–4.35 folds higher in females than in males. This is particularly notable partly because women’s oestrogen level is proved to be one of the risk factors of thyroid cancer, and the oestrogen level is actually higher in women than it is in men [
3]. This finding is similar to that of Louise Davies’ study [
12]. A recent study claimed that diagnostic changes may account for ≥ 60% of thyroid cancer cases diagnosed in women aged under 80 in many countries and approximately 50% in other countries, except Japan (30%) [
22]. A potential explanation for the rapid increase in incidence observed among females occurring early in life may be greater detection during annual obstetrical and gynecological examinations during the reproductive years, whereas the slower rise in incidence among males might reflect more frequent medical visits later in life.
In addition, there is concern about the increase in background irradiation that has occurred over the past decades [
39]. It is possible that increasing exposure to radiation from greater use of diagnostic imaging may be contributing to the increasing incidence of thyroid cancer [
40]. The iodine excess in the diet might also lead to the increasing incidence of PTC, while iodine levels in Zhejiang Province are considered to be sufficient [
32]. Some researchers presented the viewpoints that familial inheritance, mental factors and obesity could be related to the incidence of thyroid cancer [
3].
However, this study has limitations. Firstly, the population-based cancer registries did not have enough details in clinical-pathological characteristics including tumor type and size. So the clinical-pathological data were obtained from Zhejiang Cancer Hospital. However, this hospital has approximately 30% of all the cancer patients in Zhejiang province and these proportions remained stable in the study period. Therefore, the trend of clinical parameters in this hospital reflects the overall trend of cancer patients in Zhejiang province. Secondly, it does not provide the exact explanations for how the patients get increased diagnosed. We assume from our study that the potential reason is the individual’s exposure to medical care. The higher incidence of thyroid cancer in residents may be due to the medical tests excluding the other risk factors. Thirdly, since the diagnostic tool, histological criteria, and ICD coding had been modified significantly over a long period (1972–2014), the reclassification might be relatively difficult and the accuracy of these analyses might be lowered.